skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Good Afternoon 5i Team,

I'm looking to increase my exposure to the healthcare sector in Canada and the US. Can you please recommend 2-4 companies in each country that you think are worth looking into?
Read Answer Asked by David on October 18, 2021
Q: BTAI May your please provide your assessment of this company. I have been a holder for past two years only to see it decline by 45 %, with a further 15% decline today.
Do you like it, and if so, would you been keen on continuing to hold? Thank you
Read Answer Asked by Karim on October 15, 2021
Q: According to portfolio analytics I need to increase my allocation to healthcare.
Have MRK. Please rank the following from 1. growth perspective 2. safety perspective: MDT SYK ABBV ZBH REGN
Read Answer Asked by Doug on October 13, 2021
Q: As a new subscriber, I’m thoroughly impressed with your advice and 5i Research services overall - thank you for all that you do.

I currently hold ABBV, BMY, CVS, and GSK in a long-term hold, diversified RRSP portfolio. I’m not necessarily looking to add further healthcare exposure, but am very interested in the long term prospects for MRK +/- ISRG and would appreciate your opinion on them. And compared to my existing companies, would there be a suggested ranking of these six in terms of potential for long term compounding growth?
Read Answer Asked by Anthony on October 12, 2021
Q: I need to increase the healthcare allocation in my portfolio. I am considering MDT, DGX,and CVS as, I think, together they provide a good balance of strong fundamentals, yield and some growth. Do you agree, and do you have any other (non-pharma) suggestions.
Many Thanks
John
Read Answer Asked by John on October 08, 2021
Q: Hello, XENE
Any info on this company? Doesn't appear to come up on the questions or the company profile sections of the 5i website. How would you approach investing in this company, if at all?
Read Answer Asked by Alfred on October 08, 2021
Q: Hi guys

I am a steady eady dividend investor and have almost no healthcare exposure. I am looking to buy a ETF that gives me an exposure to the various healthcare sectors (not just pharmaceuticals), I am looking at overall growth for the units - capital gains and dividends - not just dividends. Wondering what your best ETF ideas would be for this sector. I saw Harvest Healthcare leaders recommended by Gordon Pape - don't know if you have some thoughts on that one - eg. how they squeeze such a high dividend out of it?

Thanks

stuart
Read Answer Asked by Stuart on October 08, 2021
Q: I own ZUH and XHC and am thinking of selling them to buy HHL for the big dividend that HHL pays (8.61%) . Is this a good idea? Or am I trading growth potential for dividends and could I actually be making a mistake?
Read Answer Asked by David on October 08, 2021
Q: I have be holding Carebook stock for over six months. The stock dipped over the past week and bit from 79 cents to 60 cents, but I cannot seem to find a driver for the news. Am I missing something? Is it a good time to buy more? iA Capital Markets just put a 'Buy' recommendation on it with a $1.60 target due to some new acquisition and other moves, but the stock has been tanking. Again, what am I missing?

Thanks in advance!
Read Answer Asked by Rossano on October 07, 2021
Q: As retirees with moderate risk tolerance, Telus is a 4% core holding in a mainly conservative dividend portfolio. We realize (and like) that Telus Health is a small part of the company. We are considering a 1% position in Well for diversification in Health sector, and would appreciate your thoughts on it. Is this an opportune time to buy, or does 5i expect tax loss selling to put more downward pressure as year-end approaches? Thank you. Edward
Read Answer Asked by Edward on October 07, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!